Skip to Content

Pharmaceuticals, Volume 4, Issue 11

2011 November - 7 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (7)

  • Article
  • Open Access
4 Citations
7,543 Views
15 Pages

11 November 2011

Serine/threonine protein kinase C βII isoform (PKCβII) or the pain receptor transient receptor potential vanilloid 1 (TRPV1) have been separately implicated in mediating heat hyperalgesia during inflammation or diabetic neuropathy. However, detailed...

  • Article
  • Open Access
7 Citations
7,747 Views
15 Pages

Photodynamic Therapy with Hypericin Improved by Targeting HSP90 Associated Proteins

  • Peter Solár,
  • Mária Chytilová,
  • Zuzana Solárová,
  • Ján Mojžiš,
  • Peter Ferenc and
  • Peter Fedoročko

10 November 2011

In this study we have focused on the response of SKBR-3 cells to both single 17-DMAG treatment as well as its combination with photodynamic therapy with hypericin. Low concentrations of 17-DMAG without any effect on survival of SKBR-3 cells significa...

  • Review
  • Open Access
5 Citations
6,934 Views
13 Pages

7 November 2011

This is a review of key factors for pharmacy and therapeutics committees to consider when developing a therapeutic interchange (TI) program for venous thromboembolism (VTE) prophylaxis. Recent patient safety initiatives aimed at reducing the incidenc...

  • Review
  • Open Access
12 Citations
8,907 Views
16 Pages

Coupling Aptamers to Short Interfering RNAs as Therapeutics

  • Laura Cerchia,
  • Carla Lucia Esposito,
  • Simona Camorani,
  • Silvia Catuogno and
  • Vittorio de Franciscis

27 October 2011

RNA-based approaches are among the most promising strategies aimed at developing safer and more effective therapeutics. RNA therapeutics include small non-coding miRNAs, small interfering RNA, RNA aptamers and more recently, small activating RNAs. Ho...

  • Review
  • Open Access
92 Citations
17,956 Views
25 Pages

Anti-Inflammatory Drug Design Using a Molecular Hybridization Approach

  • Priscila Longhin Bosquesi,
  • Thais Regina Ferreira Melo,
  • Ednir Oliveira Vizioli,
  • Jean Leandro dos Santos and
  • Man Chin Chung

27 October 2011

The design of new drugs with better physiochemical properties, adequate absorption, distribution, metabolism, and excretion, effective pharmacologic potency and lacking toxicity remains is a challenge. Inflammation is the initial trigger of several d...

  • Review
  • Open Access
46 Citations
10,285 Views
23 Pages

25 October 2011

The molecular chaperone Hsp90 holds great promise as a cancer drug target, despite some of the initial clinical trials of Hsp90 inhibitor drugs having not lived up to expectation. Effective use of these drugs will benefit greatly from a much more det...

  • Article
  • Open Access
9 Citations
6,971 Views
11 Pages

Effects of the Ethyl Acetate Fraction of Alchornea triplinervia on Healing Gastric Ulcer in Rats

  • Zeila P. Lima,
  • Flavia Bonamin,
  • Tamara R. Calvo,
  • Wagner Vilegas,
  • Lourdes C. Santos,
  • Ariane L. Rozza,
  • Claudia H. Pellizzon,
  • Lucia R. M. Rocha and
  • Clélia A. Hiruma-Lima

25 October 2011

Alchornea triplinervia (Spreng.) Muell. Arg (Euphorbiaceae) is a medicinal plant commonly used by people living in the Cerrado region of Brazil to treat gastrointestinal ulcers. We previously described the gastroprotective action of methanolic extrac...

XFacebookLinkedIn
Pharmaceuticals - ISSN 1424-8247